, Tracking Stock Market Picks
Enter Symbol:
Nxstage Medical, Inc. (NXTM) [hlAlert]

up 124.90 %

Nxstage Medical, Inc. (NXTM) rated Buy with price target $7 by SMH Capital

Posted on: Wednesday,  Aug 6, 2008  12:25 PM ET by SMH Capital

SMH Capital rated Buy Nxstage Medical, Inc. (NASDAQ: NXTM) on 08/06/2008. Previously SMH Capital rated Buy Nxstage Medical, Inc. (NASDAQ: NXTM) on
02/13/2008., when the stock price was $7.87. Since then, Nxstage Medical, Inc. has gained 124.90% as of 01/26/2016's recent price of $17.70.
If you would have followed the previous SMH Capital's recommendation on NXTM, you would have gained 124.9% of your investment in 2904 days.

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.

Sanders Morris Harris has built a unique, niche-oriented research effort that's attuned to the Southwest, yet takes a broad, global perspective. Our analysts cover some 100 companies in six broad sectors, including business services; energy; entertainment & media; financial services; and technology. Whatever the geographical focus, our research approach is fundamental and no-nonsense. We look at industries in a bottom-up way, and get to know company managements in depth, to understand their growth philosophy and their views of how their company fits within their group. And we provide straightforward, timely advice to both institutional and private clients based on that research. Unlike many Wall Street firms, which have developed arcane "recommendation matrixes," we have three simple categories of investment advice: buy, sell and hold. And we transmit our recommendations in timely, useful form. Our on-line Research Library gives clients access to the full range of company reports and bulletins generated by our analytical staff. Above all, of course, the success of SMH's research effort rests on its gifted team of analysts - a purposeful blend of experienced research pros and young, creative individuals, all of whom have honed their financial skills within the target industry or with major accounting firms. The combination works. Three of our analysts have appeared on the Wall Street Journal roster of All-Star Analysts or on the Institutional Investor's All-Star Research Team.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/6/2008 12:25 PM Buy
4.01 7.00
as of 12/24/2008
1 Week down  -11.95 %
1 Month down  -2.64 %
3 Months down  -35.56 %
1 YTD down  -17.22 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/29/2008 12:25 PM Buy
4.44 8.00
2/13/2008 9:25 AM Buy
7.87 13.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy